Clinical Trial Update: A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives [Phase 1]

View source ↗

Summary

This is a Phase 1 study to assess the pharmacokinetics and safety of ABBV-295 given by subcutaneous injection in healthy adult women with overweight or obesity …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ABBV-295

Snippet

Sponsor: AbbVie | Conditions: Healthy Volunteer | Phase 1 | Status: RECRUITING